Metabolic Phenotype of Methylmalonic Acidemia in Mice and Humans
Author Information
Author(s): Chandler Randy J, Sloan Jennifer, Fu Hong, Tsai Matthew, Stabler Sally, Allen Robert, Kaestner Klaus H, Kazazian Haig H, Venditti Charles P
Primary Institution: National Human Genome Research Institute, National Institutes of Health
Hypothesis
The study investigates the metabolic disturbances in methylmalonic acidemia and the role of skeletal muscle in metabolite production.
Conclusion
The study suggests that a significant portion of circulating methylmalonic acid originates from skeletal muscle, indicating potential therapeutic strategies targeting muscle metabolism.
Supporting Evidence
- Massive elevations of methylmalonic acid were observed in the skeletal muscle, kidneys, liver, and brain of mutant mice.
- Transplant patients displayed plasma and urine MMA levels comparable to untransplanted patients with similar enzymatic phenotypes.
- The study indicates that modulating skeletal muscle metabolism may increase metabolic capacity in methylmalonic acidemia.
Takeaway
This study shows that a lot of a harmful substance called methylmalonic acid comes from muscles, not just the liver, which could help doctors find better treatments for sick people.
Methodology
The study used a murine model with a null allele at the methylmalonyl-CoA mutase locus and compared metabolite production in mice to that in human patients with methylmalonic acidemia.
Limitations
The study's findings may not fully translate to human patients due to differences in metabolism between species.
Participant Demographics
Patients included two females aged 19 and 27, both with muto class methylmalonic acidemia, and four untransplanted patients aged 4 to 21.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website